Today: 30 June 2026

ASX Biggest Losers Today: Bapcor, Lynas, Life360 and TPG Drag Australian Shares Lower – 9 December 2025

ASX Biggest Losers Today: Bapcor, Lynas, Life360 and TPG Drag Australian Shares Lower – 9 December 2025

Sydney, 9 December 2025 – The Australian share market spent Tuesday in risk‑off mode, with the S&P/ASX 200 slipping again as investors dumped a cluster of stocks tied to profit downgrades, critical minerals volatility and regulatory scrutiny. By late morning the benchmark index was trading in the high‑8,500s, down around 0.1–0.3% after Monday’s 0.1% fall to 8,624.4 points, marking a sixth straight session of choppy, sideways trade. Market breadth was weak, with roughly two‑thirds of the ASX 200 in the red and selling concentrated in energy, gold and tech names. The Motley Fool+2Market Index+2
ASX Top Gainers Today: Immutep, Cosmo Metals, OD6 & Sunrise Energy Metals Lead the Rally (9 December 2025)

ASX Top Gainers Today: Immutep, Cosmo Metals, OD6 & Sunrise Energy Metals Lead the Rally (9 December 2025)

Despite a flat headline index, Australia’s share market is serving up double‑digit moves in small-cap resources, lithium and biotech stocks today. The S&P/ASX 200 spent Tuesday morning drifting slightly lower, extending a pattern of tight trading ranges as investors waited on the Reserve Bank of Australia’s final interest rate decision for 2025. By late morning, the benchmark was down around 0.1%–0.2%, with breadth skewed to the downside and weakness in energy, gold and parts of tech offset by pockets of strength in resources and healthcare. Market Index+1
Australian Stock Market Today: ASX 200 Slips Ahead of RBA Interest Rate Call (9 December 2025)

Australian Stock Market Today: ASX 200 Slips Ahead of RBA Interest Rate Call (9 December 2025)

The Australian stock market is treading carefully on Tuesday, 9 December 2025, with the S&P/ASX 200 index drifting lower as investors wait for the Reserve Bank of Australia’s final interest rate decision of the year and a crucial US Federal Reserve meeting later in the week. By late morning, the ASX 200 was trading around the 8,590–8,600 level, down roughly 0.3–0.4% on the day, after briefly being off only about 0.1% earlier in the session.Market Index+2ABC+2 The move extends Monday’s modest 0.1% decline to 8,624.4 points, as markets position for the RBA and a busy central‑bank week globally.mint+2News.com.au+2
9 December 2025
Best Stocks to Buy Now on the Australian Stock Market (ASX) – December 2025 Guide

Best Stocks to Buy Now on the Australian Stock Market (ASX) – December 2025 Guide

Australia’s sharemarket is in an odd mood right now: the S&P/ASX 200 is hovering in the mid‑8500s after several sessions of flat, slightly negative trading, as investors wait for the next move from the Reserve Bank of Australia.The Australian+1Beneath that sleepy headline index, though, you’ve got big rotations: materials are up more than 26% year to date and leading every other sector, while the heavyweight financials have recently suffered one of their worst months since 2022.Livewire Markets+1 That mix – booming miners, wobbling banks, and a cautious central bank – is exactly the kind of backdrop where “best stocks to buy now” really means “best stocks for your mix of growth, income and risk.”
9 December 2025
AppLovin (APP) Stock After Hours on December 8, 2025 – What to Know Before the December 9 Market Open

AppLovin (APP) Stock After Hours on December 8, 2025 – What to Know Before the December 9 Market Open

AppLovin Corporation heads into Tuesday’s session near record territory after a modest pullback and a flurry of fresh analyst, technical and valuation headlines on Monday, December 8, 2025. Here’s a deep dive into how APP traded after the bell and what investors should watch before the U.S. stock market opens on December 9. Note: All figures are as of the close and extended session on Monday, December 8, 2025, unless otherwise stated. This article is for information only and is not financial advice.
9 December 2025
Costco (COST) Stock After Hours on December 8, 2025: Tariff Lawsuit, Dividend Odds and What to Watch Before the December 9 Open

Costco (COST) Stock After Hours on December 8, 2025: Tariff Lawsuit, Dividend Odds and What to Watch Before the December 9 Open

Costco Wholesale Corporation ended Monday, December 8, 2025, with another modest pullback as investors weighed strong sales, a high valuation, a new lawsuit against the Trump administration over tariffs, and growing chatter about whether a special dividend is likely when the company reports earnings on December 11. The stock slipped during the regular session and barely budged after the bell, but the news flow around Costco got busier — and that’s what really matters heading into the opening bell on Tuesday, December 9.
9 December 2025
Home Depot (HD) Stock After the Bell on December 8, 2025: Downgrade Fallout and Investor Day Preview for the December 9 Open

Home Depot (HD) Stock After the Bell on December 8, 2025: Downgrade Fallout and Investor Day Preview for the December 9 Open

Home Depot, Inc. finished Monday’s session under pressure and stayed subdued after the bell as Wall Street digested a fresh price‑target cut, mixed analyst signals, and lingering worries about the health of the U.S. consumer ahead of the company’s Investor & Analyst Conference on Tuesday, December 9, 2025. Below is a detailed look at how Home Depot traded on December 8, what drove the move, and the key storylines investors should watch before the U.S. stock market opens on Tuesday.
Wave Life Sciences (WVE) Soars 147% on Obesity Drug Breakthrough and $250M Offering: What to Know Before the December 9 Open

Wave Life Sciences (WVE) Soars 147% on Obesity Drug Breakthrough and $250M Offering: What to Know Before the December 9 Open

Wave Life Sciences Ltd. just delivered one of the wildest biotech moves of 2025. On Monday, December 8, 2025, the stock rocketed after the company reported positive Phase 1 obesity drug data for WVE‑007 and simultaneously launched a $250 million equity offering. With the next U.S. trading session set to open on Tuesday, December 9, investors are trying to decide whether this is the beginning of a new obesity heavyweight—or a classic biotech spike that could retrace just as fast.
Salesforce (CRM) After-Hours Update for December 8, 2025: AI Momentum, Citigroup Downgrade and What to Watch Before the December 9 Open

Salesforce (CRM) After-Hours Update for December 8, 2025: AI Momentum, Citigroup Downgrade and What to Watch Before the December 9 Open

Salesforce, Inc. slipped modestly on Monday, December 8, 2025, as a week-long AI-fueled rally cooled and Wall Street digested a fresh downgrade from Citigroup alongside a flurry of new “agentic AI” announcements from the company. The stock closed at $259.53, down 0.40% on the day, snapping a six-session winning streak that had lifted shares more than 10% over the past week. StockAnalysis+1 In after-hours trading, Salesforce hovered slightly lower again, with MarketScreener showing the stock around $256.80 by 6:00 p.m. Eastern, roughly another 1% below the regular close. MarketScreener That puts investors heading into Tuesday’s December 9 open at an interesting crossroads: AI adoption and profitability are clearly accelerating, but so is debate over valuation and growth.
9 December 2025
Strategy Inc (MSTR) Stock Jumps on Nearly $1 Billion Bitcoin Buy: What to Know Before the December 9, 2025 Open

Strategy Inc (MSTR) Stock Jumps on Nearly $1 Billion Bitcoin Buy: What to Know Before the December 9, 2025 Open

After Monday’s close on December 8, 2025, Strategy Inc — the company formerly known as MicroStrategy and still trading under the ticker MSTR — is back in the spotlight. The stock climbed as the firm disclosed its largest Bitcoin purchase in more than three months, buying 10,624 BTC for about $962.7 million just as Bitcoin trades around the $90,000–$92,000 zone. Strategy+3Bankless+3Investing.com+3 Below is a complete wrap‑up of what happened after the bell on December 8 and the key things to watch before the U.S. market opens on Tuesday, December 9, 2025.
CRH Stock Soars to Record High on S&P 500 News – What Investors Need to Know Before the Market Opens on December 9, 2025

CRH Stock Soars to Record High on S&P 500 News – What Investors Need to Know Before the Market Opens on December 9, 2025

CRH plc powered to fresh record highs on Monday, December 8, 2025, after the company confirmed it will join the S&P 500 index later this month. The move caps a year of strong earnings, rising dividends, and aggressive share buybacks – and it sets up a potentially volatile open when trading resumes on Tuesday, December 9. Below is a comprehensive look at how CRH traded after the bell, what drove the move, and the key levels and catalysts to watch before the next session begins.
9 December 2025
Eli Lilly (LLY) Stock After Hours on December 8, 2025: China Mounjaro Win, Dividend Hike and What to Watch Before Tuesday’s Open

Eli Lilly (LLY) Stock After Hours on December 8, 2025: China Mounjaro Win, Dividend Hike and What to Watch Before Tuesday’s Open

Eli Lilly and Company spent Monday, December 8, 2025, digesting a wave of news: a major reimbursement win for Mounjaro in China, a 15% dividend hike, new leukemia drug data, and the return of Nobel laureate Carolyn Bertozzi to its board. At the same time, intensifying competition and price cuts in the weight‑loss drug market kept pressure on the stock. By the closing bell, Lilly shares were trading just under the psychologically important $1,000 level, still near a trillion‑dollar valuation but roughly 10% below recent highs. StockAnalysis
Robinhood (HOOD) After Hours: Indonesia Deal and Crypto Push Fuel Rally — What to Know Before the December 9, 2025 Open

Robinhood (HOOD) After Hours: Indonesia Deal and Crypto Push Fuel Rally — What to Know Before the December 9, 2025 Open

Robinhood Markets, Inc. heads into Tuesday’s U.S. session with fresh momentum after a strong move on Monday, December 8, driven by a new international expansion in Indonesia and an aggressive push deeper into crypto trading and tokenization. Below is a detailed look at how the stock traded after the bell, what actually moved HOOD on December 8, and the key catalysts to watch before the market opens on Tuesday, December 9, 2025.
CoreWeave (CRWV) Stock Slides on $2 Billion Convertible Notes Plan: What to Know Before the Market Opens on December 9, 2025

CoreWeave (CRWV) Stock Slides on $2 Billion Convertible Notes Plan: What to Know Before the Market Opens on December 9, 2025

CoreWeave, Inc. stock ended a volatile Monday lower after the AI cloud provider surprised investors with plans to raise $2 billion via convertible senior notes, adding to existing debt concerns and following recent insider share sales. The move sets up another high‑stakes trading day when U.S. markets reopen on Tuesday, December 9, 2025. CoreWeave+2Nasdaq+2 Below is a detailed look at how CoreWeave traded after the bell on December 8, the key news and fresh analysis from that date, and the main things traders and investors may want to watch before the opening bell on December 9.
9 December 2025
Intel Stock After Hours: Why INTC Rebounded on December 8, 2025 — And What to Watch Before the December 9 Open

Intel Stock After Hours: Why INTC Rebounded on December 8, 2025 — And What to Watch Before the December 9 Open

Intel Corporation just delivered another volatile session that captures exactly where the stock sits in December 2025: caught between profit‑taking after a huge rally and growing optimism about its AI and foundry reset. The intraday sell‑off reflects profit‑taking after a huge year, but the after‑hours bounce shows buyers are still eager to step in on dips when new catalysts appear.
9 December 2025
Silver Price Today, December 8, 2025: Near Record Highs as Fed Cut Bets, Supply Deficits and Short‑Squeeze Fears Collide

Silver Price Today, December 8, 2025: Near Record Highs as Fed Cut Bets, Supply Deficits and Short‑Squeeze Fears Collide

Silver is trading just under $58 per troy ounce on Monday, December 8, 2025, consolidating below last week’s record highs near $59 after one of the strongest rallies in its modern history. Spot XAG/USD is hovering around $58.1–$58.5, with today’s range roughly $57.6 to $58.7 and a 52‑week band of $28.2 to $59.3, keeping the metal within touching distance of its all‑time high. FXStreet+1 Depending on the data provider, silver is now up around 100% year‑to‑date, far outpacing gold’s roughly 60% gain and marking its best performance since the late 1970s. TradingView+2FXStreet+2 The gold/silver ratio has fallen back to about 70–72, its lowest level of 2025, underscoring how aggressively investors have rotated into the “white metal.” FXStreet+1
Australia Economic Calendar Today: RBA Rate Decision and NAB Business Survey in Focus – 9 December 2025

Australia Economic Calendar Today: RBA Rate Decision and NAB Business Survey in Focus – 9 December 2025

Australia’s economic calendar for Tuesday, 9 December 2025 is dominated by two high‑impact events: Both hit just weeks after inflation jumped to 3.8% year‑on‑year in October, the fastest pace this year, and after Q3 GDP grew 2.1% annually, the strongest in two years. Australian Bureau of Statistics+3Australian Bureau of Statistics+3Australian Bureau of Statistics+3
9 December 2025
Marvell Technology (MRVL) Plunges on Amazon and Microsoft Chip Fears: What Investors Should Know Before the Market Opens on December 9, 2025

Marvell Technology (MRVL) Plunges on Amazon and Microsoft Chip Fears: What Investors Should Know Before the Market Opens on December 9, 2025

Marvell Technology, Inc. just endured one of its most volatile sessions of the year. On Monday, December 8, 2025, the AI‑infrastructure chip maker gapped lower at the open, sold off hard through the day, and slipped a bit further after the closing bell as investors digested a cluster of negative headlines around Amazon, Microsoft and the S&P 500 index. Here’s a detailed look at what happened to Marvell stock after the bell on December 8, and what matters most before the U.S. market opens on Tuesday, December 9, 2025.

Stock Market Today

  • Abivax Jumps 36% After Cancer Safety Fear Eases for Obefazimod
    June 30, 2026, 8:33 AM EDT. Abivax shares climbed 35.77% to 113.10 euros in Paris after new data on its ulcerative colitis drug obefazimod eased cancer safety worries. The updated look, now covering 1,704 patient-years, showed cancer rates tracking with what's expected for the disease, and helped shore up obefazimod's safety profile. Shares had been under pressure after the 50 mg group in Phase 3 turned up higher malignancy numbers. Safety focus stayed high but efficacy held up, with remission topping 50% across doses and relapses. Abivax targets a U.S. FDA filing in the fourth quarter of 2026. In U.S. extended trading, shares picked up 26.4%, narrowing their year-to-date decline to 6.06%.
Go toTop